Clinical trialNCT05718921CompletedPhase 1Interventional

A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers

SponsorHangzhou Yirui Pharmaceutical Technology Co., LtdEnrollment54Atopic DermatitisPsoriasis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is to evaluate the safety, tolerability, and pharmacokinetics of YR001 topical ointment in healthy adult subjects.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Stacy Smith, Dr. MD
Encinitas, California USA
Study DirectorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

California Dermatology & Clinical Research Institute
Encinitas, California, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Placebo on high body surface areaPlacebo on high body surface area twice dailyPlacebo on low body surface areaPlacebo on middle body surface areaYR001 Dose A on high body surface areaYR001 Dose A on high body surface area twice dailyYR001 Dose A on low body surface areaYR001 Dose A on middle body surface areaYR001 Dose B on high body surface areaYR001 Dose B on high body surface area twice dailyYR001 Dose B on low body surface areaYR001 Dose B on middle body surface area

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 8 Apr 2023
Primary completion: 14 Aug 2023
Completion: 14 Dec 2023
Last update posted: 24 Jan 2024
Registered enrollment: 54
Registry id: NCT05718921

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.